Nuclear medicine firm Digirad of Poway, CA, has released preliminary financial results for 2007 (end-December 31).
Consolidated revenues are expected to reach approximately $74 million for the 12-month period. The total includes imaging services revenue of approximately $52.4 million and product revenue of approximately $21.6 million. The company's consolidated net loss is expected to range between $1.3 million to $1.5 million, including estimated stock-based compensation expense of approximately $900,000.
For 2008, Digirad projected consolidated revenues in the range of $80 million to $84 million, with imaging services revenues of $59 million to $61 million and product revenues of $21 million to $23 million. The company also anticipates its bottom line for this year to range between consolidated net income of $500,000 to a net loss of $1 million, including estimated stock-based compensation expense of $1 million.
In other news, Digirad's board of directors named R. King Nelson as chairman. He also currently serves as president and CEO of Uptake Medical of Seattle. Nelson has been on Digirad's board since March 2004.
He replaces Timothy Wollaeger, who resigned as chairman after serving in that position since January 1996.
Related Reading
Digirad's Q3 financials continue upward trend, October 25, 2007
Digirad posts Q2 profit, August 7, 2007
Digirad debuts nSpeed, June 4, 2007
Digirad completes acquisition of Ultrascan, May 2, 2007
Digirad's revenues advance in 2006, February 20, 2007
Copyright © 2008 AuntMinnie.com
